The carboxyl terminus of VEGF-A is a potential target for anti-angiogenic therapy
Crossref DOI link: https://doi.org/10.1007/s10456-014-9444-3
Published Online: 2014-10-02
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Carter, James G.
Gammons, Melissa V. R.
Damodaran, Gopinath
Churchill, Amanda J.
Harper, Steven J.
Bates, David O.
License valid from 2014-10-02